Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Ryu

Showing results (451-460 of 646) with videos related to

Pageof 65
Sort By:
Clinical Breast Cancer|December 1, 2024
Adjuvant Trastuzumab Plus Pertuzumab Versus Trastuzumab Alone in Patients Achieving Pathologic Complete Response After Chemotherapy With Trastuzumab and Pertuzumab: A Retrospective Cohort StudyYoonwon Kook, Jee Hung Kim, Ji Soo Jang, et al.
Breast Cancer Research and Treatment|September 16, 2018
Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancerJai Min Ryu, Hee Jun Choi, Isaac Kim, et al.
International Journal of Surgery (London, England)|January 23, 2026
Autologous vs. implant-based breast reconstruction and long-term mental disorder risk: a retrospective cohort study emulating a target trialDanbee Kang, Woong Ki Park, Chanwoo Park, et al.
The American Journal of Surgical Pathology|April 2, 2025
HER2 mRNA Score From Quantitative ERBB2 mRNA Expression of Oncotype Dx : Can It Replace the HER2 Immunohistochemistry?Hyunwoo Lee, Jai Min Ryu, Se Kyung Lee, et al.
European Radiology|March 25, 2025
Digital mammography with AI-based computer-aided diagnosis to predict neoadjuvant chemotherapy response in HER2-positive and triple-negative breast cancer patients: comparison with MRIHaejung Kim, Ji Soo Choi, Sang Ah Chi, et al.
Journal of Breast Cancer|April 7, 2017
Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control StudyJai Min Ryu, Hyun-June Paik, Sungmin Park, et al.
Journal of Breast Cancer|August 29, 2022
Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of <i>In Situ</i> CarcinomaJun-Hee Lee, Hyunjun Lee, Yoon Ju Bang, et al.
Scientific Reports|October 21, 2021
Author Correction: Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patientsSoo Youn Cho, Jeong Hoon Lee, Jai Min Ryu, et al.
Scientific Reports|August 31, 2021
Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patientsSoo Youn Cho, Jeong Hoon Lee, Jai Min Ryu, et al.
Chemical Communications (Cambridge, England)|July 15, 2016
Sunlight-assisted, biocatalytic formate synthesis from CO2 and water using silicon-based photoelectrochemical cellsEun Jin Son, Jong Wan Ko, Su Keun Kuk, et al.
Pageof 65

Showing results (451-460 of 646) with videos related to

Sort By:
Pageof 65
Clinical Breast Cancer|December 1, 2024
Adjuvant Trastuzumab Plus Pertuzumab Versus Trastuzumab Alone in Patients Achieving Pathologic Complete Response After Chemotherapy With Trastuzumab and Pertuzumab: A Retrospective Cohort StudyYoonwon Kook, Jee Hung Kim, Ji Soo Jang, et al.
Breast Cancer Research and Treatment|September 16, 2018
Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancerJai Min Ryu, Hee Jun Choi, Isaac Kim, et al.
International Journal of Surgery (London, England)|January 23, 2026
Autologous vs. implant-based breast reconstruction and long-term mental disorder risk: a retrospective cohort study emulating a target trialDanbee Kang, Woong Ki Park, Chanwoo Park, et al.
The American Journal of Surgical Pathology|April 2, 2025
HER2 mRNA Score From Quantitative ERBB2 mRNA Expression of Oncotype Dx : Can It Replace the HER2 Immunohistochemistry?Hyunwoo Lee, Jai Min Ryu, Se Kyung Lee, et al.
European Radiology|March 25, 2025
Digital mammography with AI-based computer-aided diagnosis to predict neoadjuvant chemotherapy response in HER2-positive and triple-negative breast cancer patients: comparison with MRIHaejung Kim, Ji Soo Choi, Sang Ah Chi, et al.
Journal of Breast Cancer|April 7, 2017
Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control StudyJai Min Ryu, Hyun-June Paik, Sungmin Park, et al.
Journal of Breast Cancer|August 29, 2022
Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of <i>In Situ</i> CarcinomaJun-Hee Lee, Hyunjun Lee, Yoon Ju Bang, et al.
Scientific Reports|October 21, 2021
Author Correction: Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patientsSoo Youn Cho, Jeong Hoon Lee, Jai Min Ryu, et al.
Scientific Reports|August 31, 2021
Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patientsSoo Youn Cho, Jeong Hoon Lee, Jai Min Ryu, et al.
Chemical Communications (Cambridge, England)|July 15, 2016
Sunlight-assisted, biocatalytic formate synthesis from CO2 and water using silicon-based photoelectrochemical cellsEun Jin Son, Jong Wan Ko, Su Keun Kuk, et al.
Pageof 65